Galmed Pharmaceuticals Ltd. (GLMD) Has Soared To A New High On Study Results

Galmed Pharmaceuticals Ltd. (GLMD) reported results from its Phase 2 study of Aramchol 600mg Tuesday morning. The study demonstrated a statistically significant reduction in liver fat.

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>